| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260296.1 |
Ponatinib |
Brain lower grade glioma |
0.024723947 |
Resistant |
| ENSG00000260296.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011981237 |
Resistant |
| ENSG00000260296.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023813053 |
Sensitive |
| ENSG00000260296.1 |
Ponatinib |
Stomach adenocarcinoma |
0.049149118 |
Sensitive |
| ENSG00000260296.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041700899 |
Resistant |
